跳至主要内容
临床试验/EUCTR2005-000390-22-FI
EUCTR2005-000390-22-FI进行中(未招募)不适用

Antikoagulanttihoito varfariinilla sydäntahdistimen asennuksen yhteydessä - Tahdistin-Varfariini

Turku University Hospital0 个研究点目标入组 400 人开始时间: 2005年1月28日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Any patient scheduled for an elective implantation of pacemaker or arrhythmia device currently treated with warfarin, aspirin or neither.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Excessive intensity of anticoagulation as defined by International Normalized Ratio (INR) of more than 3.0
  • - Known bleeding disorder or hemorrhagic diathesis
  • - Known contraindication for pacemaker implantation
  • - Previously implanted mechanical heart valve prosthesis
  • - Any contraindication for interrupting warfarin treatment
  • - Significant anemia as defined by hemoglobin level of less than 100 g/L

研究者

相似试验

Antikoagulanttihoito varfariinilla sydäntahdistimen... | 临床试验